Guardant Health (GH) Return on Equity (2018 - 2026)

Guardant Health (GH) has 9 years of Return on Equity data on file, last reported at 0.03% in Q1 2026.

• Quarterly Return on Equity rose 1.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (up 1.0% YoY) and the FY2025 annual result came in at 0.03%, up 49.0% from the prior year.
• Return on Equity grew to 0.03% in Q1 2026 per GH's latest filing, from 0.02% in the prior quarter.
• The five-year high for Return on Equity was 0.17% in Q3 2024, with the low at 0.85% in Q1 2023.
• Average Return on Equity over 5 years is 0.05%, with a median of 0.01% recorded in 2022.
• Year-over-year, Return on Equity tumbled 84 bps in 2023 and jumped 81 bps in 2024.
• Guardant Health's Return on Equity stood at 0.06% in 2022, then surged by 57 bps to 0.02% in 2023, then jumped by 276 bps to 0.04% in 2024, then sank by 58 bps to 0.02% in 2025, then surged by 68 bps to 0.03% in 2026.
• Business Quant data shows GH's Return on Equity at 0.03% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.